Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis

Human Reproduction

Volumn 20, Issue 3, 2005, Pages 802-806

  van Dunne F M ^a,b   Doggen, C J M ^a   Heemskerk, M ^a   Rosendaal, F R ^a   Helmerhorst, F M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

Factor V Leiden; Fecundity; Miscarriage; Time to pregnancy

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FEMALE FERTILITY; FETUS DEVELOPMENT; FIRST TRIMESTER PREGNANCY; GENE MUTATION; GENOTYPE; HETEROZYGOTE DETECTION; HUMAN; MAJOR CLINICAL STUDY; PARITY; QUESTIONNAIRE; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; SPONTANEOUS ABORTION; VEIN THROMBOSIS;

EID: 15844412303     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh640     Document Type: Article

References (22)

1. Bertina RM, Koeleman BP, Koster T, Rosendaal F, Dirven R, de Ronde H, van der Velden P and Reitsma P (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369, 64-67.
2. Burton GJ, Jauniaux E and Watson AL (1999) Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited. Am J Obstet Gynecol 181,718-724.
3. De Groot CJ, Bloemenkamp KW, Duvekot EJ, Helmerhorst FM, Bertina RM, Van Der Meer F, De Ronde H, Oei SG, Kanhai HH and Rosendaal FR (1999) Preeclampsia and genetic risk factors for thrombosis: a case-control study. Am J Obstet Gynecol 181,975-980.
4. Dilley A, Benito C, Hooper WC, Austin H, Miller C, El-Jamil M, Cottrell S, Benson J, Evart BL, Patterson-Bamett A et al. (2002) Mutations in the factor V, prothrombin and MTHFR genes are not risk factors for recurrent fetal loss. J Matern Fetal Neonat Med 11,176-182.
5. Dudding TE and Attia J (2004) The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis. Thromb Haemost 91,700-711.
6. Göpel W, Ludwig M, Junge AK, Kohlmann T, Diedrich K and Moller J (2001) Selection pressure for the factor-V-Leiden mutation and embryo implantation. Lancet 358,1238-1239.
7. Hundsdoerfer P, Vetter B, Stover B, Bassir C, Scholz T, Grimmer I, Monch E, Ziemer S, Rossi R and Kulozik AE (2003) Homozygous and double heterozygous Factor V Leiden and Factor II G20210A genotypes predispose infants to thromboembolism but are not associated with an increase of foetal loss. Thromb Haemost 90,628-635.
8. Hustin J and Schaaps JP (1987) Echographic [corrected] and anatomic studies of the maternotrophoblastic border during the first trimester of pregnancy. Am J Obstet Gynecol 157,162-168.
9. Joffe M, Villard L, Li Z, Plowman R and Vessey M (1993) Long-term recall of fime-to-pregnancy. Fertil Steril 60,99-104.
10. Kovalevsky G, Gracia CR, Berlin JA, Sammel MD and Barnhart KT (2004) Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis. Arch Intern Med 164,558-563.
11. Lindqvist PG, Svensson PJ, Marsaal K, Grennert L, Luterkort M and Dählback B (1999) Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost 81,532-537.
12. Lindqvist PG, Zöller B and Dählback B (2001) Improved hemoglobin status and reduced menstrual blood loss among female carriers of factor V Leiden - an evolutionary advantage? Thromb Haemost 86,1122-1123.
13. Majerus PW (1994) Human genetics. Bad blood by mutation. Nature 369, 14-15.
14. Morrison ER, Miedzybrodzka ZH, Campbell DM, Haites NE, Wilson BJ, Watson MS, Greaves M and Vickers MA (2002) Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost 87,779-785.
15. Pauer HU, Voigt-Tschirschwitz T, Hinney B, Burfeind P, Wolf C, Emons G and Neesen J (2003) Analyses of three common thrombophilic gene mutations in German women with recurrent abortions. Acta Obst Gynecol Scand 82,942-947.
16. Philipp T, Philipp K, Reiner A, Beer F and Kalousek DK (2003) Embryoscopic and cytogenetic analysis of 233 missed abortions: factors involved in the pathogenesis of developmental defects of early failed pregnancies. Hum Reprod 18,1724-1732.
17. Rai R, Shlebak A, Cohen H, Backos M, Holmes Z, Marriott K and Regan L (2001) Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod 16,961-965.
18. Rees DC (1996) The population genetics of factor V Leiden (Arg506Gln). Br J Haematol 95,579-586.
19. Rey E, Kahn SR, David M and Shrier I (2003) Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361(9361),901-908.
20. Roqué H, Paidas MJ, Funai EF, Kuczynski E and Lockwood CJ (2004) Maternal thrombophilias are not associated with early pregnancy loss. Thromb Haemost 91,290-295.
21. Rosendaal FR, Koster T, Vandenbroucke JP and Reitsma PH (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85,1504-1508.
22. Zinaman MJ, Clegg ED, Brown CC, O'Connor J and Selevan SG (1996) Estimates of human fertility and pregnancy loss. Fertil Steril 65,503-509.